PubRank

G Schernthaner

Author PubWeight™ 132.20‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 A randomised, 52-week, treat-to-target trial comparing insulin detemir with insulin glargine when administered as add-on to glucose-lowering drugs in insulin-naive people with type 2 diabetes. Diabetologia 2008 4.62
2 Hypomagnesaemia in type 2 (non-insulin-dependent) diabetes mellitus is not corrected by improvement of long-term metabolic control. Diabetologia 1992 2.72
3 Bicentric evaluation of a teaching and treatment programme for type 1 (insulin-dependent) diabetic patients: improvement of metabolic control and other measures of diabetes care for up to 22 months. Diabetologia 1983 2.18
4 Haemostatic abnormalities persist despite glycaemic improvement by insulin therapy in lean type 2 diabetic patients. Thromb Haemost 1994 2.09
5 Can people with type 2 diabetes live longer than those without? A comparison of mortality in people initiated with metformin or sulphonylurea monotherapy and matched, non-diabetic controls. Diabetes Obes Metab 2014 1.99
6 Medical antihyperglycaemic treatment of type 2 diabetes mellitus: update of the evidence-based guideline of the German Diabetes Association. Exp Clin Endocrinol Diabetes 2009 1.65
7 Glucose-lowering with exogenous insulin monotherapy in type 2 diabetes: dose association with all-cause mortality, cardiovascular events and cancer. Diabetes Obes Metab 2014 1.51
8 Diabetes classification: grey zones, sound and smoke: Action LADA 1. Diabetes Metab Res Rev 2008 1.50
9 Impact of weight loss on inflammatory proteins and their association with the insulin resistance syndrome in morbidly obese patients. Arterioscler Thromb Vasc Biol 2003 1.44
10 [Lispro-insulin analogs in therapy of diabetes]. Wien Klin Wochenschr 1997 1.40
11 Night time blood pressure in diabetic patients--the submerged portion of the iceberg? Nephrol Dial Transplant 1999 1.39
12 Long-term efficacy and tolerability of add-on pioglitazone therapy to failing monotherapy compared with addition of gliclazide or metformin in patients with type 2 diabetes. Diabetologia 2005 1.29
13 Serum osteocalcin levels in diabetes mellitus: analysis of the type of diabetes and microvascular complications. Diabetologia 1988 1.23
14 Long-term therapy with addition of pioglitazone to metformin compared with the addition of gliclazide to metformin in patients with type 2 diabetes: a randomized, comparative study. Diabetes Metab Res Rev 2005 1.18
15 A long-term comparison of pioglitazone and gliclazide in patients with Type 2 diabetes mellitus: a randomized, double-blind, parallel-group comparison trial. Diabet Med 2005 1.17
16 Enhanced serum levels of thiobarbituric-acid-reactive substances in diabetes mellitus. Am J Med 1995 1.14
17 Immunoglobulin allotype markers and HLA DR genes in type I diabetes mellitus. Metabolism 1984 1.10
18 Effects of marked weight loss on plasma levels of adiponectin, markers of chronic subclinical inflammation and insulin resistance in morbidly obese women. Int J Obes (Lond) 2005 1.08
19 Humoral immunodeficiency to bacterial antigens in patients with juvenile onset diabetes mellitus. Diabetologia 1976 1.08
20 Coxsackie B, mumps, rubella, and cytomegalovirus specific IgM responses in patients with juvenile-onset insulin-dependent diabetes mellitus in Britain, Austria, and Australia. Lancet 1985 1.08
21 Decreased vascular prostacyclin in juvenile-onset diabetes. N Engl J Med 1979 1.06
22 Pro- and anti-inflammatory cytokines in latent autoimmune diabetes in adults, type 1 and type 2 diabetes patients: Action LADA 4. Diabetologia 2011 1.03
23 Thrombin generation in morbid obesity: significant reduction after weight loss. J Thromb Haemost 2010 1.02
24 Effect of metformin on peripheral insulin sensitivity in non insulin dependent diabetes mellitus. Diabete Metab 1986 1.01
25 Serum neuron-specific enolase is a useful tumor marker for small cell lung cancer. Cancer 1990 1.00
26 Seropositive rheumatoid arthritis associated with decreased diffusion capacity of the lung. Ann Rheum Dis 1976 0.99
27 Asymmetrical dimethylarginine is related to renal function, chronic inflammation and macroangiopathy in patients with Type 2 diabetes and albuminuria. Diabet Med 2007 0.99
28 Incidence and management of severe hypoglycemia in 434 adults with insulin-dependent diabetes mellitus. Diabetes Care 1985 0.98
29 Concentrations of seven trace elements in different hematological matrices in patients with type 2 diabetes as compared to healthy controls. Biol Trace Elem Res 2001 0.97
30 Natural killer cell activity and antibody-dependent cellular cytotoxicity in patients under various immunosuppressive regimens. Clin Immunol Immunopathol 1987 0.95
31 The effect of insulin treatment on HbA1c, body weight and lipids in type 2 diabetic patients with secondary-failure to sulfonylureas. A five year follow-up study. Horm Metab Res 1992 0.95
32 Serum concentrations of retinol-binding protein 4 in women with and without gestational diabetes. Diabetologia 2008 0.95
33 Autoantibodies to oxidised low density lipoproteins in IDDM are inversely related to metabolic control and microvascular complications. Diabetologia 1998 0.94
34 Proceedings from an international consensus meeting on posttransplantation diabetes mellitus: recommendations and future directions. Am J Transplant 2014 0.94
35 Ia-Type alloantigens and humoral autoimmune responsiveness in insulin-dependent diabetes mellitus. Metabolism 1979 0.92
36 The impact of risk factors and more stringent diagnostic criteria of gestational diabetes on outcomes in central European women. J Clin Endocrinol Metab 2008 0.92
37 Severe hyperprolactinaemia is associated with decreased insulin binding in vitro and insulin resistance in vivo. Diabetologia 1985 0.91
38 Soluble CD40L in patients with morbid obesity: significant reduction after bariatric surgery. Eur J Clin Invest 2006 0.91
39 HLA-DR3 and HLA-DR5 associated thyrotoxicosis--two different types of toxic diffuse goiter. J Clin Endocrinol Metab 1983 0.91
40 Insulin secretion, insulin sensitivity and hepatic insulin extraction in primary hyperparathyroidism before and after surgery. Clin Endocrinol (Oxf) 1992 0.91
41 Relative hypoleptinaemia in women with mild gestational diabetes mellitus. Diabet Med 1999 0.91
42 Thrombogenic factors are related to urinary albumin excretion rate in type 1 (insulin-dependent) and type 2 (non-insulin-dependent) diabetic patients. Diabetologia 1993 0.90
43 Effects of 8-wk alpha-glucosidase inhibition on metabolic control, C-peptide secretion, hepatic glucose output, and peripheral insulin sensitivity in poorly controlled type II diabetic patients. Diabetes Care 1989 0.90
44 Effects of the alpha-glucosidase inhibitor 1 desoxynojirimycin (Bay m 1099) on postprandial blood glucose, serum insulin and C-peptide levels in type II diabetic patients. Eur J Clin Pharmacol 1986 0.90
45 Slow gastric emptying in type I diabetes: relation to autonomic and peripheral neuropathy, blood glucose, and glycemic control. Diabetes Care 1997 0.89
46 Follow-up of cyclosporin A treatment in type 1 (insulin-dependent) diabetes mellitus: lack of long-term effects. Diabetologia 1991 0.89
47 Peripheral insulin resistance in primary hyperparathyroidism. Metabolism 1983 0.88
48 Glycosylated haemoglobin in renal failure. Diabetologia 1980 0.88
49 Impact of peripheral arterial disease in patients with diabetes--results from PROactive (PROactive 11). Atherosclerosis 2008 0.88
50 Sensitivity of platelets to prostaglandins in cornary heart disease and angina pectoris. Prostaglandins 1981 0.88
51 Nondipping of nocturnal blood pressure is related to urinary albumin excretion rate in patients with type 2 diabetes mellitus. Am J Hypertens 1996 0.88
52 The importance of HLA genes to susceptibility in the development of juvenile diabetes mellitus. A study of 93 patients and 68 first degree blood relations. Diabete Metab 1977 0.87
53 Improved metabolic control decreases platelet activation markers in patients with type-2 diabetes. Eur J Clin Invest 2004 0.87
54 [Islet-cell antibodies in juvenile diabetes mellitus (author's transl)]. Dtsch Med Wochenschr 1977 0.86
55 The soluble form of the receptor of advanced glycation endproducts increases after bariatric surgery in morbid obesity. Int J Obes (Lond) 2012 0.86
56 Successful parathyroidectomy in primary hyperparathyroidism: a clinical follow-up study of 212 consecutive patients. Surgery 1987 0.86
57 Activation of coagulation and fibrinolysis in patients with arteriosclerosis: relation to localization of vessel disease and risk factors. Thromb Res 1990 0.86
58 Immunoglobulin G-insulin antibodies and immune region-associated alloantigens in insulin-dependent diabetes mellitus. J Clin Endocrinol Metab 1979 0.85
59 Hypomagnesemia in type II diabetes: effect of a 3-month replacement therapy. Diabetes Care 1995 0.85
60 Serum neuron-specific enolase. A marker for responses to therapy in seminoma. Cancer 1987 0.84
61 Influence of interferon alfa-2b with or without folinic acid on pharmacokinetics of fluorouracil. Semin Oncol 1992 0.84
62 Improvement of glucose tolerance in type 2 diabetic patients: traditional vs. modern insulin regimens (results from the Austrian Biaspart Study). Horm Metab Res 2005 0.84
63 Trp64Arg polymorphism of the beta3-adrenergic receptor gene in pregnancy: association with mild gestational diabetes mellitus. J Clin Endocrinol Metab 1999 0.84
64 Letter: Is HLA-B7 a marker associated with a protective gene in juvenile-onset diabetes mellitus? N Engl J Med 1976 0.84
65 Dawn phenomenon and Somogyi effect in IDDM. Diabetes Care 1989 0.84
66 Pulmonary dysfunction in type 1 diabetes in relation to metabolic long-term control and to incipient diabetic nephropathy. Nephron 1996 0.84
67 B-lymphocyte alloantigens and insulin-dependent diabetes mellitus. Lancet 1977 0.83
68 Decreased peripheral insulin sensitivity in acromegalic patients. Exp Clin Endocrinol 1990 0.83
69 Diabetes and bone. Horm Metab Res 2010 0.83
70 Apolipoproteins (A-I, A-II, B), Lp(a) lipoprotein and lecithin: cholesterol acyltransferase activity in diabetes mellitus. Atherosclerosis 1983 0.83
71 Effects of cyclosporin A upon humoral and cellular immune parameters in insulin-dependent diabetes mellitus type I: a long-term follow-up study. J Endocrinol 1989 0.83
72 The efficacy and safety of miglitol therapy compared with glibenclamide in patients with NIDDM inadequately controlled by diet alone. Diabetes Care 1997 0.83
73 A case of malignant mastocytosis with circulating mast cell precursors: biologic and phenotypic characterization of the malignant clone. Leukemia 1996 0.83
74 Decreased protein C levels in patients with insulin-dependent type I diabetes mellitus. Diabetes 1986 0.83
75 Glucose metabolism and insulin sensitivity in patients on chronic hemodialysis. Metabolism 1985 0.82
76 Characteristics, cardiovascular comorbidity and medicines management in patients with type 2 diabetes and CKD: results of the IRIDIEM study. Kidney Blood Press Res 2010 0.82
77 Metabolic effects of isradipine versus hydrochlorothiazide in diabetes mellitus. Hypertension 1991 0.82
78 Letter: Genetic factors on insulin antibodies in juvenile-onset diabetes. N Engl J Med 1976 0.82
79 Effect of experimentally induced diabetes on swine vascular prostacyclin (PGI2) synthesis. Artery 1980 0.81
80 Low levels of Sex-Hormone-Binding Globulin predict insulin requirement in patients with gestational diabetes mellitus. Exp Clin Endocrinol Diabetes 2001 0.81
81 Coxsackie-B-virus-specific IgM responses, complement-fixing islet-cell antibodies, HLA DR antigens, and C-peptide secretion in insulin-dependent diabetes mellitus. Lancet 1985 0.81
82 Cisapride versus placebo for 8 weeks on glycemic control and gastric emptying in insulin-dependent diabetes: a double blind cross-over trial. J Clin Endocrinol Metab 1999 0.81
83 Gastric emptying in Type II (non-insulin-dependent) diabetes mellitus before and after therapy readjustment: no influence of actual blood glucose concentration. Diabetologia 1999 0.81
84 Primary hyperparathyroidism is associated with decreased insulin receptor binding and glucose intolerance. Calcif Tissue Int 1984 0.81
85 HL-A8, W15 and T3 in juvenile onset diabetes mellitus. Horm Metab Res 1975 0.81
86 Effect of vitamin E supplementation on platelet thromboxane A2 production in type I diabetic patients. Double-blind crossover trial. Diabetes 1988 0.81
87 Increased serum concentrations of adhesion molecules but not of chemokines in patients with Type 2 diabetes compared with patients with Type 1 diabetes and latent autoimmune diabetes in adult age: action LADA 5. Diabet Med 2012 0.80
88 Cytokine production in patients with newly diagnosed insulin-dependent (type I) diabetes mellitus. Eur J Clin Invest 1988 0.80
89 HLA-DR antigens in insulin-dependent diabetes. Arch Dis Child 1981 0.80
90 [The influence of metabolic control on chemotactic activity in insulin-dependent diabetes mellitus (author's transl)]. Wien Klin Wochenschr 1978 0.80
91 Changes in liver tests during 1-year treatment of patients with Type 2 diabetes with pioglitazone, metformin or gliclazide. Diabet Med 2005 0.80
92 A two-step screening algorithm including fasting plasma glucose measurement and a risk estimation model is an accurate strategy for detecting gestational diabetes mellitus. Diabetologia 2012 0.80
93 Platelet aggregation and reversible platelet aggregates in type I-diabetes staged by retinal fluorescein angiography. Atherosclerosis 1981 0.79
94 [Decreased plasma carnitine in Type I diabetes mellitus]. Klin Wochenschr 1991 0.79
95 Improved glycaemic control with miglitol in inadequately-controlled type 2 diabetics. Diabetes Res Clin Pract 2001 0.79
96 Genetic heterogeneity in thyrotoxicosis patients with and without endocrine ophthalmopathy. Diabete Metab 1977 0.79
97 Development of insulin-dependent diabetes mellitus in a patient with chronic hepatitis C during therapy with interferon-alpha. Eur J Gastroenterol Hepatol 2001 0.79
98 Differential expression of receptors for advanced glycation end products on monocytes in patients with IDDM. Diabetologia 1998 0.79
99 Circulating ADMA concentrations are elevated in hypopituitary adults with and without growth hormone deficiency. Eur J Clin Invest 2005 0.79
100 Vascular prostacyclin, platelet sensitivity to prostaglandins and platelet-specific proteins in diabetes mellitus. Analysis of type of diabetes, state of metabolic control and diabetic microangiopathy. Horm Metab Res Suppl 1981 0.79
101 Serum concentrations of laminin P1 in diabetics with advanced nephropathy. J Clin Pathol 1988 0.79
102 Clinical pharmacokinetics of 5-fluorouracil. Influence of the biomodulating agents interferon, dipyridamole and folinic acid alone and in combination. Arzneimittelforschung 1993 0.79
103 Growth hormone replacement therapy is not associated with retinal changes. J Clin Endocrinol Metab 2000 0.78
104 Contribution of postprandial insulin and glucose to glucose disposal in normal and insulin-resistant obese subjects. J Clin Endocrinol Metab 1991 0.78
105 Miglitol combined with metformin improves glycaemic control in type 2 diabetes. Diabetes Obes Metab 2001 0.78
106 Influence of metabolic control of insulin-dependent diabetes on plasma nucleotide levels (cAMP, cGMP) during bicycle exercise. Diabet Med 1987 0.78
107 Gonadotropin responsiveness to luteinizing hormone releasing hormone in prepubertal and pubertal patients with growth hormone deficiency. Acta Paediatr Scand 1982 0.78
108 Immunogenicity of human insulin (Novo) or pork monocomponent insulin in HLA-DR-typed insulin-dependent diabetic individuals. Diabetes Care 1983 0.78
109 Renal and metabolic effects of 1-year treatment with ramipril or atenolol in NIDDM patients with microalbuminuria. Diabetologia 1996 0.78
110 HLA CW3 in thyrotoxicosis patients with and without endocrine ophthalmopathy. Tissue Antigens 1976 0.78
111 Insulin receptor binding to monocytes, insulin secretion, and glucose tolerance following metformin treatment. Results of a double-blind cross-over study in type II diabetics. Diabetes 1983 0.77
112 Lung elasticity in juvenile-onset diabetes mellitus. Am Rev Respir Dis 1977 0.77
113 No effect of homocysteine-lowering therapy on vascular inflammation and haemostasis in peripheral arterial occlusive disease. Eur J Clin Invest 2006 0.77
114 Long-term treatment with nifedipine reduces urinary albumin excretion and glomerular filtration rate in normotensive type 1 diabetic patients with microalbuminuria. Acta Diabetol 1994 0.77
115 [Clinical significance of the radioimmunological determination of beta-thromboglobulin and platelet factor 4]. Acta Med Austriaca Suppl 1979 0.77
116 Receptor binding properties of human insulin (recombinant DNA) and human proinsulin and their interaction at the receptor site. Diabetes Care 1987 0.77
117 Beta-cell hypersecretion and not reduced hepatic insulin extraction is the main cause of hyperinsulinemia in obese nondiabetic subjects. Metabolism 1992 0.77
118 Evidence for genetic control of anti-insulin immunity in juvenile onset diabetes mellitus. Diabete Metab 1977 0.77
119 [Glycosylated hemoglobin and diabetes--self monitoring (compliance) in depressed and non-depressed type I diabetic patients]. Psychother Psychosom Med Psychol 1991 0.77
120 Increased angiotensin-converting enzyme activities in diabetes mellitus: analysis of diabetes type, state of metabolic control and occurrence of diabetic vascular disease. J Clin Pathol 1984 0.77
121 Do HLA-DR-typing and measurement of TSH-receptor antibodies help in the prediction of the clinical course of Graves' thyrotoxicosis after antithyroid drug treatment? Acta Endocrinol Suppl (Copenh) 1987 0.77
122 Elevated plasma beta-thromboglobulin levels in multiple myeloma and in polycythaemia vera. Acta Haematol 1979 0.77
123 Solid and cystic tumour of the pancreas; a hormonal-dependent neoplasm? Histopathology 1988 0.77
124 No effect of insulin treatment or glycemic improvement on plasma carnitine levels in type 2 diabetic patients. Clin Investig 1993 0.77
125 Increased platelet malondialdehyde, but normal platelet sensitivity to adenosine-5-diphosphate and prostacyclin in well-controlled type 1 diabetics without vascular complications. Diabetes Res 1986 0.77
126 [Malignant aldosteronoma in the differential diagnosis of Conn syndrome]. Acta Med Austriaca 1988 0.76
127 Antibodies to pancreatic duct cells in Sjögren's syndrome and rheumatoid arthritis. Gut 1977 0.76
128 Juvenile diabetes mellitus: HLA-antigen frequencies dependent on the age of onset of the disease. J Immunogenet 1976 0.76
129 [Gestagen receptor-positive, solid-cystic acinar-cell tumor of the pancreas]. Dtsch Med Wochenschr 1989 0.76
130 The effect of near-normoglycemic control on plasma factor VIII/von Willebrand factor and fibrin degradation products in insulin-dependent diabetic patients. J Clin Endocrinol Metab 1989 0.76
131 Glycosylated haemoglobin in chronic renal failure. Lancet 1979 0.76
132 Pharmacokinetic aspects of interferon alfa-2b after intrahepatic or intraperitoneal administration. Semin Oncol 1992 0.76
133 Concentrations of circulating P-selectin are increased in patients with newly diagnosed insulin-dependent diabetes mellitus. Exp Clin Endocrinol Diabetes 1998 0.76
134 Beta-cell function recovery is not the only factor responsible for remission in type I diabetics: evaluation of C-peptide secretion in diabetic children after first metabolic recompensation and at partial remission phase. J Endocrinol Invest 1984 0.76
135 Effects of sex and age on growth hormone response to growth hormone-releasing hormone in healthy individuals. J Clin Endocrinol Metab 1987 0.76
136 Evaluation of glucose tolerance, insulin secretion, and insulin action in patients with primary hyperparathyroidism before and after surgery. Calcif Tissue Int 1990 0.76
137 Decreased insulin receptor binding in hyperthyroidism. Klin Wochenschr 1984 0.76
138 The effects of ramipril on glucose tolerance, insulin secretion, and insulin sensitivity in patients with hypertension. J Cardiovasc Pharmacol 1991 0.76
139 Letter: Respiratory function in rheumatoid arthritis. Br Med J 1975 0.75
140 [Progress in therapy of diabetes with insulin analogs?]. Wien Klin Wochenschr 1997 0.75
141 Changes in body composition after 9 months of treatment with exenatide twice daily versus glimepiride: comment letter on Jendle et al. Diabetes Obes Metab 2010 0.75
142 Beta cell function in siblings of diabetic children and HLA type. Arch Dis Child 1983 0.75
143 [Lack of effect of ACE inhibition on severe proteinuria in diabetic nephropathy--a 6-month-long study]. Schweiz Med Wochenschr 1988 0.75
144 [Critical evaluation of fructosamine as a control parameter in the assessment of diabetic metabolic regulation]. Klin Wochenschr 1989 0.75
145 [The investigation of the endocrine partial functions in post-traumatic insufficiency of the anterior pituitary gland (author's transl)]. Wien Klin Wochenschr 1974 0.75
146 [Glycohemoglobin. Possibilities and limits in diabetes control]. Dtsch Med Wochenschr 1981 0.75
147 Missing evidence of a correlation between Hashimoto-thyroiditis and HLA antigens [proceedings]. Diabete Metab 1976 0.75
148 Humoral antibacterial immunity in first degree relatives of insulin-dependent diabetics. Diabete Metab 1978 0.75
149 [Value of the determination of glycosylated proteins and glycosylated hemoglobin in therapy control of diabetic patients]. Z Med Lab Diagn 1989 0.75
150 Influence of acute experimental hypercalcemia on peripheral insulin sensitivity in healthy subjects. Diabetes Res 1986 0.75
151 Prolactin, Growth hormone, thyrotropin, insulin, C-peptide, glucose tolerance and pituitary-gonadal axis in patients with compensated renal failure. Proc Eur Dial Transplant Assoc 1979 0.75
152 [C-peptide, IgG-insulin antibodies, island cell antibodies and immune response genes in diabetes mellitus]. Verh Dtsch Ges Inn Med 1978 0.75
153 [HLA typing and determination of thyroid gland stimulating antibodies in hyperthyroid patients]. Verh Dtsch Ges Inn Med 1981 0.75
154 Proinsulin in pregnant women with normal glucose tolerance or mild gestational diabetes mellitus. Exp Clin Endocrinol Diabetes 1999 0.75
155 Effect of danazol-induced chronic hyperglucagonaemia on glucose tolerance and turnover. Eur J Clin Invest 1995 0.75
156 [Migration inhibition of mononuclear cells in idiopathic adrenal insufficiency. Inhibition of migration of mononuclear cells with adrenal microsomes and blocking of the reaction by adrenal antibodies (author's transl)]. Klin Wochenschr 1976 0.75
157 Left ventricular function in well-controlled insulin-dependent (type I) diabetics--an echophonocardiographic study. Cardiology 1986 0.75
158 Prevalence of microalbuminuria in maturity onset primarily non-insulin-requiring diabetes mellitus: effect of disease duration, glycemic control, and mean systemic blood pressure. J Diabet Complications 1988 0.75
159 HLA-antigens and autoimmunity in idiopathic Addison's disease [proceedings]. Diabete Metab 1976 0.75
160 [New viewpoints on the pathogenesis of diabetes mellitus]. Acta Med Austriaca 1978 0.75
161 Affinity of IgG-insulin antibodies to human (recombinant DNA) insulin and porcine insulin in insulin-treated diabetic individuals with and without insulin resistance. Diabetes Care 1987 0.75
162 Enhanced anticoagulant response to activated protein C in patients with IDDM. Diabetes 1995 0.75
163 [Evaluation of a new method for determining glycated hemoglobin with monoclonal antibodies (DCA 2000)]. Wien Klin Wochenschr 1996 0.75
164 Metabolic effects of biosynthetic human proinsulin in type 2 diabetes mellitus. Eur J Clin Invest 1989 0.75
165 [Cellular immune reactivity in patients with multiple myeloma]. Acta Med Austriaca 1978 0.75
166 A serine/alanine polymorphism in the nucleotide-binding fold-2 of the sulphonylurea receptor-1 (S1369A) is associated with enhanced glucose-induced insulin secretion during pregnancy. J Inherit Metab Dis 2000 0.75
167 [Metastasizing, endocrine active pancreatic tumor with hormone conversion from gastrin to insulin]. Wien Med Wochenschr 1987 0.75
168 [Platelet sensitivity to prostacyclin (PGI2) in patients with juvenile-onset diabetes mellitus (author's transl)]. Wien Klin Wochenschr 1981 0.75
169 Coxsackie B4 viral infection, anti-islet immunity and immunogenetics in insulin-dependent diabetes mellitus. Acta Diabetol Lat 1978 0.75
170 Clinical long-term results after parathyroidectomy for primary hyperparathyroidism. Acta Chir Scand 1987 0.75
171 Prediction of relapse or long-term remission in hyperthyroid Graves' disease. Lancet 1980 0.75
172 [Thrombocyte function and systemic effect of prostaglandin I2 inhalation]. Acta Med Austriaca Suppl 1979 0.75
173 Enhanced growth hormone responses to growth hormone releasing hormone in male type I diabetic patients. Horm Metab Res 1991 0.75
174 Individualized risk management in diabetics: how to implement best practice guidelines--design and concept of the IRIDIEM studies. Kidney Blood Press Res 2004 0.75
175 [Juvenile diabetes mellitus: decreased prostacyclin (PGI2) synthesis in the vascular wall]. Vasa 1979 0.75
176 Letter: Intra-HLA recombination frequency in juvenile diabetes. Lancet 1976 0.75
177 TSH-receptor antibodies, HLA B8 and thyroid autoantibodies in patients with Graves' disease in therapeutically induced euthyroidism. Experientia 1979 0.75
178 Increased growth hormone responses to growth hormone releasing hormone and thyrotropin releasing hormone in patients with metastatic testicular cancer. Horm Metab Res 1990 0.75
179 [Pancreatic duct antibodies in Sjogren's syndrome and in chronic polyarthritis]. Verh Dtsch Ges Rheumatol 1978 0.75
180 Effect of cholinergic muscarinic receptor blockade on human growth hormone (GH)-releasing hormone-(1-44)-induced GH secretion in acromegaly and type I diabetes mellitus. J Clin Endocrinol Metab 1986 0.75
181 Coagulation factors of contact phase of haemostasis are normal in well-controlled type-I diabetic patients despite presence of diabetic retinopathy. Diabetes Res 1988 0.75
182 Apolipoprotein (a) levels in patients with type 1 diabetes mellitus are unrelated to metabolic control or vascular disease. Wien Klin Wochenschr 1994 0.75
183 [Multi-organ specific autoimmunity in idiopathic adrenal insufficiency: autosensitization to steroid hormone-producing cells and antigens of the anterior pituitary gland (author's transl)]. Wien Klin Wochenschr 1978 0.75
184 [Diabetes therapy with continuous insulin infusion by a portable pump: metabolic effects of short-term treatment and long-term results in problem patients]. Acta Med Austriaca 1982 0.75
185 [Plasmapheresis--an enrichment in the therapy of autoimmune endocrinopathies?]. Dtsch Med Wochenschr 1984 0.75
186 The effect of insulin treatment on the balance between tissue plasminogen activator and plasminogen activator inhibitor-1 in type 2 diabetic patients. Thromb Haemost 1992 0.75
187 Increased susceptibility to endocrine opthalmopathy in HLA CW3 positive thyrotoxicosis patients [proceedings]. Diabete Metab 1976 0.75
188 Diastolic abnormalities might precede systolic abnormalities of left ventricular function in type 1 (insulin-dependent) diabetes mellitus. Diabetologia 1986 0.75
189 [The clinical importance of glycohaemoglobin (HbA1) (author's transl)]. Wien Klin Wochenschr Suppl 1980 0.75
190 [Insulin receptor and postreceptor disorders: significance for the development and therapy of carbohydrate metabolic disorders]. Acta Med Austriaca 1984 0.75
191 The clinical relevance of fetal hemoglobin in IDDM and NIDDM patients. Diabetes Care 1995 0.75
192 Alterations of the internal elastic membrane in the coeliac trunk and its branches. Jpn Circ J 1976 0.75
193 [The skin in chronic immune complex mesangioproliferative glomerulonephritis]. Verh Dtsch Ges Inn Med 1978 0.75
194 [Effects of muscular exercise on non-glucoregulatory hormones (T3, rT3, T4, TSH, prolactin, FSH, LH) in type I diabetics (author's transl)]. Acta Med Austriaca 1981 0.75
195 Investigation of selective [3H]iloprost binding sites on human platelet membranes. Prog Clin Biol Res 1987 0.75
196 Plasma concentrations of plbatelet-specific proteins in coronary artery disease. Cardiology 1981 0.75
197 Apolipoproteins in diabetes mellitus. Monogr Atheroscler 1985 0.75
198 [Thyreotoxic crisis triggered by stimulation of the adrenal gland medulla]. Schweiz Med Wochenschr 1975 0.75
199 [Glycohemoglobin (HbA1): a valuable parameter for the evaluation of long-term control of diabetes]. Dtsch Med Wochenschr 1982 0.75
200 [The significance of immunologic mechanisms in the pathogenesis of renal diseases. 2. Immune complex nephritis, cell mediated reactions, pyelonephritis, therapeutic possibilities and conclusions]. Med Klin 1978 0.75
201 Childhood obesity: serum lipoproteins, glucose and insulin concentrations after an oral glucose load. Artery 1980 0.75
202 [Clinical and immunological studies in idiopathic adrenal insufficiency]. Wien Klin Wochenschr 1975 0.75
203 [Diabetes mellitus and carbohydrate metabolism in primary hyperparathyroidism]. Wien Klin Wochenschr 1993 0.75
204 [Influence of aging on glucose tolerance and insulin secretion (author's transl)]. Aktuelle Gerontol 1981 0.75
205 [Epidemiological research on primary hyperparathyroidism. A prospective multicenter study]. Dtsch Med Wochenschr 1988 0.75
206 Humoral anti - insulin immunity and HLA factors in juvenile onset diabetes [proceedings]. Diabete Metab 1976 0.75
207 Effects of somatostatin and oral potassium administration on terbutaline-induced hypokalemia. Am Rev Respir Dis 1989 0.75
208 [Immunopathomechanisms in pulmo-renal syndrome]. Wien Med Wochenschr 1978 0.75
209 Clinical and immunologic studies of HLA-DR typed insulin-dependent diabetics--a mini-review. Exp Clin Endocrinol 1984 0.75
210 Improvement of insulin action is an important part of the antidiabetic effect of metformin. Horm Metab Res Suppl 1985 0.75
211 Lack of association between Hashimoto's thyroiditis and SD-locus HLA antigens. Diabete Metab 1977 0.75
212 Apolipoprotein (a) levels and atherogenic lipid fractions in relation to the degree of urinary albumin excretion in type 2 diabetes mellitus. Nephron 1994 0.75
213 [Effect of muscular exercise and metabolic control on cortisol, growth hormone, plasma-epinephrine and plasma-norepinephrine in type-I diabetics [author's transl)]. Acta Med Austriaca 1981 0.75
214 [Hypotrypsinemia in diabetes mellitus]. Acta Med Austriaca Suppl 1979 0.75
215 [Age-corrected analysis of glucose tolerance in blood relations of patients with juvenile onset diabetes mellitus]. Z Gesamte Inn Med 1976 0.75
216 [Immunopathogenesis and immunotherapy of type 1 diabetes mellitus]. Z Med Lab Diagn 1989 0.75
217 Mixtures of human intermediate and human regular insulin in type 1 diabetic patients. Evaluation of free insulin levels and insulin action on glucose metabolism after combined and separate subcutaneous administration. Diabetes Res Clin Pract 1988 0.75
218 [Study of age and sex dependance in renal clearances with radioisotopes (author's transl)]. Aktuelle Gerontol 1976 0.75
219 [Microfluorometric demonstration of thyroglobulin antibodies with the defined antigen substrate spheres (DASS) system]. Z Immunitatsforsch Exp Klin Immunol 1976 0.75
220 [Pharmacokinetic aspects of the combination of interferon-alpha-2b and folic acid with fluorouracil]. Arzneimittelforschung 1991 0.75
221 [Lung function disorders in Sjögren's syndrome]. Z Rheumatol 1977 0.75
222 [HDL-cholesterol in diabetes mellitus. Analysis of type of diabetes, therapy, duration of disease and metabolic control (author's transl)]. Wien Klin Wochenschr 1980 0.75
223 [Glitazones critically evaluated]. Dtsch Med Wochenschr 2007 0.75
224 Insulin binding of human and porcine monocomponent insulin to monocytes in type 1 (insulin-dependent) diabetic patients and control subjects. Diabetologia 1983 0.75
225 [Behavior of hemodynamics and catecholamines in patients undergoing excision of pheochromocytoma]. Acta Med Austriaca 1988 0.75
226 The importance of HLA-B8, BW15, CW3 and B7 in juvenile onset diabetes mellitus [proceedings]. Diabete Metab 1976 0.75
227 [Thyrotoxicosis and sarcoidosis of the thyroid and the lung (author's transl)]. Med Klin 1979 0.75
228 Beta-thromboblogulin lowered by dipyridamole in diabetes. Lancet 1979 0.75
229 High prevalence of abnormal circadian blood pressure regulation and impaired glucose tolerance in adults with hypopituitarism. Exp Clin Endocrinol Diabetes 2005 0.75
230 [Significance of arterial blood pressure for the development of microalbuminuria and retinopathy in type I diabetes mellitus]. Klin Wochenschr 1988 0.75
231 Prostacyclins in diabetes: an electrophysiological study. Ophthalmic Res 1993 0.75
232 Letter: Glucose-tolerance tests in HL-A-typed relatives of patients with juvenile onset diabetes mellitus. Lancet 1975 0.75
233 [Pharmacokinetics and local availability of mitomycin. The influence of vasoconstriction and chemoembolization]. Arzneimittelforschung 1991 0.75
234 [Cellular prevention of infections in diabetes mellitus]. Verh Dtsch Ges Inn Med 1978 0.75
235 [Biochemical and micromorphological investigation of lipids in small intestinal mucosa of patients with diabetes mellitus (author's transl)]. Klin Wochenschr 1981 0.75
236 [Angiotensin II type-1 receptor antagonists and diabetes mellitus]. Wien Med Wochenschr 2001 0.75
237 [The significance of immunologic mechanisms in the pathogenesis of renal diseases. 1. The immune competent system, complement, immune mechanisms and coagulation anaphylactic reactions, antibody mediated cytotoxic reactions]. Med Klin 1978 0.75
238 Antibody-dependent killer-cell function in insulin-dependent diabetes mellitus. J Endocrinol Invest 1980 0.75
239 Cellular and humoral immunity to adrenal antigens in patients with idiopathic Addison's disease. Z Immunitatsforsch Immunobiol 1976 0.75
240 No evidence for increased growth hormone responses to growth hormone-releasing hormone in patients with diabetic retinopathy. Diabetes 1987 0.75
241 [Clinical experiences following the surgical therapy of asymptomatic, oligosymptomatic and symptomatic parathyroid gland hyperfunction]. Klin Wochenschr 1986 0.75
242 Decreased plasma levels of protein S in well-controlled type I diabetes mellitus. Thromb Haemost 1987 0.75
243 Adiponectin concentrations increase during acute FFA elevation in humans treated with rosiglitazone. Horm Metab Res 2007 0.75
244 [Falipamil for decreasing intraoperative heart rate in pheochromocytoma]. Acta Med Austriaca 1988 0.75
245 Initial urinary albumin excretion determines the progression of microalbuminuria in patients with type-2 diabetes and normotensive blood pressure values despite improved metabolic control. Diabetes Res Clin Pract 1998 0.75
246 Comparison of insulin receptor binding to monocytes and erythrocytes in newly diagnosed type II diabetes mellitus. Horm Metab Res 1982 0.75
247 The European Exenatide study of long-term exenatide vs. glimepiride for type 2 diabetes: rationale and patient characteristics. Diabetes Obes Metab 2009 0.75
248 Activation of platelet in vivo function and plasma levels of catecholamines and growth hormone during bicycle exercise in juvenile diabetes and healthy individuals. Curr Probl Clin Biochem 1982 0.75
249 [Serum concentration of triiodothyronine in autonomous thyroid gland adenoma]. Acta Med Austriaca 1975 0.75
250 [New aspects in the pathogenesis and in the course of type-I-diabetes mellitus (author's transl)]. Wien Klin Wochenschr Suppl 1980 0.75
251 [Etiology and pathophysiology of the diabetes mellitus syndromes]. Wien Med Wochenschr 1985 0.75
252 [Viral infection, autoimmunity and immunogenetics in insulin-dependent diabetes mellitus]. Verh Dtsch Ges Inn Med 1978 0.75
253 Psychological moderator variables and metabolic control in recent onset type 1 diabetic patients--a two year longitudinal study. J Psychosom Res 1994 0.75
254 HL-A antigens in idiopathic Addison's disease. Z Immunitatsforsch Exp Klin Immunol 1975 0.75
255 [Chemotherapy of malignant adrenal gland tumors]. Acta Med Austriaca 1988 0.75
256 Soluble selectins in IDDM: possible association with lipids? Diabet Med 1997 0.75
257 Platelet aggregation and metabolic control are not affected by calcium antagonist treatment in type II diabetes mellitus. J Cardiovasc Pharmacol 1990 0.75
258 Intestinal metabolism of plasma free fatty acids in streptozotocin diabetic rats. Lipids 1984 0.75
259 Exercise induces in vivo platelet activation in patients with coronary artery disease and in healthy individuals. Haemostasis 1983 0.75
260 [Endocrine studies on the Prader-Labhart-Willi syndrome: puberty induction in a 19-year-old boy after long-term treatment with an LHRH analog]. Exp Clin Endocrinol 1983 0.75
261 HLA antigens in families of juvenile onset diabetics [proceedings]. Diabete Metab 1976 0.75
262 [Pharmacokinetic aspects of dosage increase of recombinant interferon alpha-2B in patients following intraperitoneal and intra-arterial application]. Wien Klin Wochenschr 1990 0.75
263 The effect of pirenzepine on growth hormone and blood glucose levels in type I diabetes mellitus. A controlled study in patients on basal bolus insulin treatment. Acta Endocrinol (Copenh) 1988 0.75
264 Growth hormone, prolactin and insulin following arginine infusion in primary hyperparathyroidism before and after parathyroidectomy. Acta Endocrinol (Copenh) 1983 0.75
265 Mitogen-induced lymphocyte transformation during haemodialysis. Proc Eur Dial Transplant Assoc 1979 0.75
266 Magnesium supplementation in type 2 diabetes. Diabetes Care 1998 0.75
267 Demonstration of thyroglobulin-binding cells in Hashimoto patients by fluoroimmunocytoadherence. Lancet 1977 0.75
268 Autoantibodies to adrenal medullary and thyroid calcitonin cells in type I diabetes mellitus--a prospective study. J Autoimmun 1988 0.75
269 [Age dependence of vascular prostacyclin formation in man (author's transl)]. Aktuelle Gerontol 1980 0.75
270 Effect of growth hormone releasing hormone on growth hormone secretion in type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia 1987 0.75
271 Immediate-type allergy against insulin itself: clinical and immunologic studies on a diabetic patient with insulin intolerance. Diabetes Care 1981 0.75
272 Effect of bezafibrate on plasma lipids, lipoproteins, apolipoproteins AI, AII and B and LCAT activity in hyperlipidemic, non-insulin-dependent diabetics. Atherosclerosis 1982 0.75
273 Demonstration and characterization of thyroglobulin-binding peripheral blood cells in Hashimoto patients by fluoroimmunocytoadherence. Clin Immunol Immunopathol 1978 0.75
274 Platelet proteins (beta-TG and PF4) in atherosclerosis and related diseases. Artery 1980 0.75
275 [HL-A system and diabetes mellitus]. Schweiz Med Wochenschr 1976 0.75
276 Pituitary thyrotroph function and thyroid hormones in longstanding type-II diabetes mellitus before and after insulin treatment. Exp Clin Endocrinol 1987 0.75
277 [beta-Cell residual function in juvenile diabetes mellitus (author's transl)]. Monatsschr Kinderheilkd 1980 0.75
278 [Comparative quantitative rapid determination of blood sugar by means of various reflectometer-systems]. Wien Med Wochenschr 1976 0.75
279 Reduction of cardiovascular mortality in type-2 diabetes by aggressive and early intervention strategies. Wien Klin Wochenschr 1999 0.75